CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial

<p>Abstract</p> <p>Background</p> <p>Worldwide, over 10 million people are killed or hospitalized because of traumatic brain injury each year. About 90% of deaths occur in low- and middle-income countries. The condition mostly affects young adults, and many experience l...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Dewan Yashbir, Komolafe Edward O, Mejía-Mantilla Jorge H, Perel Pablo, Roberts Ian, Shakur Haleema
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2012-06-01
Edice:Trials
Témata:
Antifibrinolytic
Clinical trial
Emergency care
Intracranial bleeding
Tranexamic acid
Traumatic brain injury
On-line přístup:http://www.trialsjournal.com/content/13/1/87
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky